高橋 俊文
,
伊藤 克弘
,
寒野 徹
,
岡田 崇
,
東 義人
,
山田 仁
… For the management of patients with castration-resistant prostate cancer with bone metastases, bisphosphonates and denosumab are used to prevent skeletal related events. … Osteonecrosis of the jaw and hypocalcemia have been reported in patients treated with denosumab, but there have been few reports of atypical femoral fracture (AFF). … Here, we report a case of AFF after dosing denosumab. … Combined-androgen blockade therapy and denosumab were initiated in April 2014. …
IR
DOI
Ichushi Web